Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Acute kidney injury occurs when the kidneys suddenly stop filtering waste products from the blood. Kidney failure affects body fluids, electrolytes, and acid-base balance. Acute kidney injury involves prerenal, postrenal, and intrinsic failures. Depending upon the severity of the injury, the treatment involves hemodialysis and continuous renal replacement therapy. Though treatment is not meant to completely cure the kidney, but to improve the kidney function.

The global acute kidney injury treatment market is estimated to be valued at US$ 1,857.8 million in 2021 and is expected to exhibit a CAGR of 7.2% during the forecast period (2021-2028).

Figure 1.Global Acute Kidney Injury Treatment Market Share (%) in Terms of Value, By Type, 2021

Acute Kidney Injury Treatment  | Coherent Market Insights

Increasing incidence of acute kidney injuries is expected to drive the market growth during the forecast period.

The increasing incidence of acute kidney injuries is expected to drive the global acute kidney injury treatment market growth over the forecast period. For instance, according to International Society of Nephrology, there are around 13.3 million cases of acute kidney injury worldwide each year. Additionally, 1.7 million deaths are caused by acute kidney injury per year globally.

Figure 2.Global Acute Kidney Injury Treatment Market Share (%), By Treatment, 2021

Acute Kidney Injury Treatment  | Coherent Market Insights

Increasing technological advancements are expected to drive the market growth during the forecast period.

Key players operating in the market are focusing on development of treatments for acute kidney injury, which is expected to drive the global acute kidney injury treatment market growth during the forecast period. For instance, in December 2020, Medtronic plc, a global leader in medical technology, services, and solutions, announced the U.S. commercial launch of the Carpediem cardio-renal pediatric dialysis emergency machine. The first of its kind Carpediem system is indicated for use in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy. It is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms.

request-sample

Acute Kidney Injury Treatment Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,857.8 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 7.2% 2028 Value Projection: US$ 3,031.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Prerenal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Postrenal Acute Kidney Injury
  • By Treatment: Therapy, Drugs
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Quark Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG., B. Braun Melsungen AG,  Fresenius Medical Care, Medtronic,  Astellas Pharma Inc., Sentien Biotechnologies, Inc., Teva Pharmaceutical Industries Ltd.,  Asahi Kasei Medical Co., AM-Pharma B.V,  Teleflex Incorporated,  Cure Medical, LLC, and  Angion Biomedia Corp

Growth Drivers:
  • Increasing incidence of acute kidney injuries
  • Increasing technological advancements
  • Increasing government  initiatives
Restraints & Challenges:
  • High costs for acute kidney injury treatment
  • Lack of awareness among the people regarding the acute kidney injury treatment

Global Acute Kidney Injury Treatment Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 235 million infected individuals worldwide as of October 7, 2021.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.

Furthermore, players operating in the global acute kidney injury treatment market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials required for manufacturing drug formulations due to irregularities in transportation. Moreover, distributors are experiencing irregular demand for products from the retailers due to an increase in the number of patients suffering from COVID-19 and other life threatening disorders.

Global Acute Kidney Injury Treatment Market: Restraint

The major factors that hinder the growth of the global acute kidney injury treatment market include high costs for acute kidney injury treatment and lack of awareness among the people regarding the acute kidney injury treatment. For instance, according to an article published in Karger Journals in 2017, stated that in the U.S. acute kidney injury is associated with an increase in hospitalization costs that range from US$ 5.4 to US$ 24.0 billion. The patients with high treatment cost are those with acute kidney injury of sufficient severity to require dialysis, where cost increases relative to patients without acute kidney injury range from US$ 11,016 to US$ 42,077 per hospitalization.

Key Players

Quark Pharmaceuticals, Inc.,  Baxter International, Inc.,  Novartis AG.,  B. Braun Melsungen AG,  Fresenius Medical Care,  Medtronic,  Astellas Pharma Inc.,  Sentien Biotechnologies, Inc., Teva Pharmaceutical Industries Ltd., Asahi Kasei Medical Co., AM-Pharma B.V, Teleflex Incorporated, Cure Medical, LLC, and Angion Biomedia Corp

Acute kidney injury (AKI) is characterized by a sudden loss in kidney function, characterized increasing serum creatinine level without loss of urine. Acute kidney injury affects other organs of the human body such as heart, lungs, and brain. Acute kidney injury is most common in patients admitted at hospital, intensive care units (ICU), and among older adults. Signs and symptoms of acute kidney failure may include decreased urine output, although occasionally urine output remains normal, fluid retention, causing swelling in legs, ankles or feet, shortness of breath, fatigue, confusion, nausea, weakness, irregular heartbeat, chest pain or pressure, and seizures or coma in severe cases.

Market Dynamics

Key players operating in the global acute kidney injury treatment market are focusing on adoption of growth strategies such as product launch, regulatory approval, and research and development for the treatment of acute kidney injury, which is expected to drive the market growth during the forecast period. For instance, in October 2019, Astellas Pharma Inc. is a Japanese multinational pharmaceutical company., announced that the U.S. Food and Drug Administration (FDA) granted fast track designation for the development of ASP1128 for patients at increased risk of developing moderate to severe acute kidney injury (AKI) after coronary artery bypass and/or valve (CABG/V) surgery. The fast track designation is intended to facilitate the development, and expedite the US FDA review, of drugs to treat serious and life-threatening conditions so that, if approved, the compounds can reach the market more expeditiously. Furthermore, in April 2021, Angion Biomedica Corp a late-stage biopharmaceutical company and Vifor Pharma a global pharmaceutical company announced completion of enrollment for Angion’s AKI-002-15 study, a Phase II trial of ANG-3777 in patients at risk of cardiac-surgery associated acute kidney injury (CSA-AKI). This indication is part of the ANG-3777 license agreement both parties signed in November 2020.

Key features of the study:

  • This report provides in-depth analysis of the global acute kidney injury treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global acute kidney injury treatment market based on the following parameters – company highlights, product portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Quark Pharmaceuticals, Inc.,  Baxter International, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care,  Medtronic, Astellas Pharma Inc., Sentien Biotechnologies, Inc., Teva Pharmaceutical Industries Ltd., Asahi Kasei Medical Co., AM-Pharma B.V, Teleflex Incorporated, Cure Medical, LLC, and Angion Biomedia Corp
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global acute kidney injury treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute kidney injury treatment market

Detailed Segmentation:

  • Global Acute Kidney Injury Treatment Market, By Type :
    • Prerenal Acute Kidney Injury
    • Intrinsic Renal Acute Kidney Injury
    • Postrenal Acute Kidney Injury
  • Global Acute Kidney Injury Treatment Market, By Treatment  :
    • Therapy
    • Drugs
  • Global Acute Kidney Injury Treatment Market, By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Acute Kidney Injury Treatment Market, By Region:
    • North America
      • By Type
        • Prerenal Acute Kidney Injury
        • Intrinsic Renal Acute Kidney Injury
        • Postrenal Acute Kidney Injury
      •  By Treatment
        • Therapy
        • Drugs
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Type
        • Prerenal Acute Kidney Injury
        • Intrinsic Renal Acute Kidney Injury
        • Postrenal Acute Kidney Injury
      •  By Treatment
        • Therapy
        • Drugs
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type
        • Prerenal Acute Kidney Injury
        • Intrinsic Renal Acute Kidney Injury
        • Postrenal Acute Kidney Injury
      •  By Treatment
        • Therapy
        • Drugs
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Prerenal Acute Kidney Injury
        • Intrinsic Renal Acute Kidney Injury
        • Postrenal Acute Kidney Injury
      •  By Treatment
        • Therapy
        • Drugs
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type
        • Prerenal Acute Kidney Injury
        • Intrinsic Renal Acute Kidney Injury
        • Postrenal Acute Kidney Injury
      •  By Treatment
        • Therapy
        • Drugs
        • itis
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Prerenal Acute Kidney Injury
        • Intrinsic Renal Acute Kidney Injury
        • Postrenal Acute Kidney Injury
      •  By Treatment
        • Therapy
        • Drugs
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Quark Pharmaceuticals, Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Baxter International, Inc.
    • Novartis AG
    • B. Braun Melsungen AG
    • Fresenius Medical Care
    • Medtronic
    • Astellas Pharma Inc.
    • Sentien Biotechnologies, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Asahi Kasei Medical Co.
    • AM-Pharma B.V.
    • Teleflex Incorporated
    • Cure Medical, LLC
    • Angion Biomedia Corp

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type 
      • Market Snapshot, By Treatment
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
    • Impact Analysis
    • Pipeline Analysis
    • Regulatory Scenario
    • Market Trends
    • Key Developments
    • Epidemiology
    • PEST Analysis
    • Brand Analysis
  4. Global Acute Kidney Injury Treatment Market– Impact of Coronavirus (COVID-19) Pandemic
    • Economic Impact
    • Impact on Clinical Trials and Drug Development
  5. Global Acute Kidney Injury Treatment Market, By Type, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Prerenal Acute Kidney Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Intrinsic Renal Acute Kidney Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Postrenal Acute Kidney Injury
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
  6. Global Acute Kidney Injury Treatment Market, By Treatment, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
  7. Global Acute Kidney Injury Treatment Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
  8. Global Acute Kidney Injury Treatment Market, By Region, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2028
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Region/Countries, 2017 – 2028, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Quark Pharmaceuticals, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Baxter International, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Novartis AG.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Braun Melsungen AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fresenius Medical Care
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Medtronic
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Astellas Pharma Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sentien Biotechnologies, Inc.  
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Asahi Kasei Medical Co.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • AM-Pharma B.V
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teleflex Incorporated
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Cure Medical, LLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Angion Biomedia Corp
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
    • Analyst Views
  10. Section
    • Research Methodology
    • About us

*Browse 27 market data tables and 31 figures on "Acute Kidney Injury Treatment Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The global acute kidney injury treatment market size is estimated to be valued at US$ 1,857.8 million in 2021 and is expected to exhibit a CAGR of 7.2/b% between 2021 and 2028.
Factors such as increasing incidence of acute kidney injuries, increasing technological advancements, and increasing government initiatives are expected to drive the market growth during the forecast period.
Drug segment is expected to hold a major market share during the forecast period.
The major factors hampering growth of the global acute kidney injury treatment market include high costs for acute kidney injury treatment and lack of awareness among the people regarding the acute kidney injury treatment.
Major players operating in the market include Quark Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Astellas Pharma Inc., Sentien Biotechnologies, Inc., Teva Pharmaceutical Industries Ltd., Asahi Kasei Medical Co., AM-Pharma B.V, Teleflex Incorporated, Cure Medical, LLC, and Angion Biomedia Corp
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.